•  
  •  
 

Corresponding Author

Hamza Mohamed Mohamed

Document Type

Original Article

Abstract

Background: Obesity is identified by a BMI of more than thirty kg/m2, whereas severe obesity is identified as a body mass index exceeding Forty kg/m2. Up to one-third of those seeking bariatric surgery are diagnosed with Type 2 DM, indicating a significant correlation between obesity and T2DM.

Aim: To compare laparoscopic sleeve gastrectomy to SASI (single anastomosis sleeve ileal bypass) operation as a treatment for Morbidly Obese cases with type 2 diabetes.

Patients and Methods: This prospective interventional study included sixty individuals who were selected from attendees of outpatient General Surgery clinics of Al Azhar University Hospitals. Samples were collected by the systematic random method from February 2023 to December 2023.

Results: Most of the cases reported dose reduction of anti-DM medications post-operative in 86.7% of subjects had laparoscopic sleeve gastrectomy, while medication has not been changed in 13.3%. At the same time, 93.3% of subjects who had Sas operation reported dose reduction of anti-DM medications, and medication had not been changed in 6.7%. There was no significant variation among both groups concerning age, sex, BMI, baseline anti-DM treatment, fasting blood glucose (FBG) regarding pre-operative value at three three-month follow and at six three-month follow-ups, weight loss, and complication rate (bleeding, stenosis, and biliary gastritis).

Conclusion: Laparoscopic sleeve gastrectomy was as effective as Sasoperation as a treatment for Morbidly Obese cases with Type 2 DM, as the two groups had similar results in our study.

Keywords

laparoscopic sleeve gastrectomy; Sasi operation; Obesity; Type 2 Diabetes Mellitus (T2DM)

Subject Area

General Surgery

Download

Share

COinS